[{"Physician_Profile_ID": "451716", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Scientific and Medical Affairs", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005403", "Total_Amount_of_Payment_USDollars": "1555.63", "Date_of_Payment": "10/15/2013", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "111722328", "Name_of_Associated_Covered_Drug_or_Biological1": "MYCAMINE", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Prospective Antifungal Therapy Alliance which includes surveillance of invasive fungal infections IFIs among patients hospitalized at 25 medical centers in North America between 2004 and 2008", "Research_Information_Link": "", "Context_of_Research": ""}, {"Physician_Profile_ID": "451716", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_Name": "Astellas Scientific and Medical Affairs", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_State": "IL", "Applicable_Manufacturer_or_Applicable_GPO_Making_Payment_ID": "100000005403", "Total_Amount_of_Payment_USDollars": "1555.63", "Date_of_Payment": "01/15/2014", "Form_of_Payment_or_Transfer_of_Value": "In-kind items and services", "Record_ID": "173819882", "Name_of_Associated_Covered_Drug_or_Biological1": "Mycamine", "Name_of_Associated_Covered_Drug_or_Biological2": "", "Name_of_Study": "Prospective Antifungal Therapy PATH Registry", "Research_Information_Link": "", "Context_of_Research": ""}]